“Subtype performance of the ancillary diagnostic 23- and 35-gene expression profile (GEP) tests for difficult-to-diagnose melanocytic lesions” (2023) SKIN The Journal of Cutaneous Medicine, 7(3), p. s214. doi:10.25251/skin.7.supp.214.